Skip to main content
. 2021 Sep 23;22(19):10247. doi: 10.3390/ijms221910247

Table 2.

Patients’ clinicopathological information.

Total no. Patients of Glioblastoma (n = 58) No. (%)
Age
<65 40 (68.4%)
≥65 18 (31.6%)
Gender
male 34 (58.6%)
female 24 (41.4%)
IDH1 status
wildtype 56 (96.6%)
mutation 2 (3.4%)
Treatment modalities
Chemotherapy 24 (41.4%)
Radiotherapy 34 (58.6%)